Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 625

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1C
Chunk 625
---
 will assess and monitor whether any of our compensation
policies and programs has the potential to encourage excessive risk taking. While each committee is responsible for evaluating certain
risks and overseeing the management of such risks, our entire board of directors will be regularly informed through committee reports
about such risks.

Code
of Business Conduct and Ethics

Our
board of directors have adopted a code of business conduct and ethics applicable to all of our directors, officers (including our principal
executive officer, principal financial officer, and principal accounting officer) and all global employees in accordance with applicable
federal securities laws and corporate governance rules of the Nasdaq Capital Market. Our code of business conduct and ethics will be
available on our website. Any amendments to the code of business conduct and ethics, or waivers of its requirements, will, if required,
be disclosed on our website.

60

Corporate
Governance Guidelines

Our
board of directors has adopted corporate governance guidelines, a copy of which will be available on our website.

Director
Compensation

We
did not provide any cash compensation to any of our directors during the year ended December 31, 2024, in their capacity as directors.
However, on August 27, 2024, each non-employee director was granted an option to purchase 25,000 shares of our common stock under the
2023 Omnibus Plan, with an exercise price of $5.02. Each such option contained vesting terms in which half the options immediately vested
and the remaining half vested in six months. The options have a 10-year term.

Item
11. Executive Compensation.

This
section discusses the material components of the executive compensation program for the following persons: (i) all persons serving as
our principal executive officers during 2024 and (ii) the most highly compensated of our other executive officers who received compensation
during 2024 of at least $100,000 and who were executive officers on December 31, 2024. We refer to these persons as our “named
executive officers” and their positions are as follows:

Summary
Compensation Table

The
following table shows the compensation paid by us during the 2024 and 2023 fiscal years to our named executive officers.

    Name
    and principal position 
    Year 
    Salary
                                                                  ($)  
    Bonus  
    Stock
                                                                  Awards  
    Option
                                                                  Awards
                                            (3)  
    All
                                            Other
                                                                  Compensation  
    Total